Latest Articles
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer - OncLive
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer OncLive
Published: April 9, 2025, 2 p.m.
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... MSN
Published: April 9, 2025, 12:35 a.m.
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" - BioSpace
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" BioSpace
Published: April 8, 2025, 8:04 p.m.
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" - Yahoo
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" Yahoo
Published: April 8, 2025, 2:12 p.m.
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" - Business Wire
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D" Business Wire
Published: April 8, 2025, 2:12 p.m.
Clinical Trial Participation Gaps in Endometrial Cancer - Physician's Weekly
Clinical Trial Participation Gaps in Endometrial Cancer Physician's Weekly
Published: April 8, 2025, 1:53 p.m.
Dual PD-1/CTLA-4 Inhibition With Cadonilimab Plus Lenvatinib Yields Disease Control in Advanced Endometrial Cancer - OncLive
Dual PD-1/CTLA-4 Inhibition With Cadonilimab Plus Lenvatinib Yields Disease Control in Advanced Endometrial Cancer OncLive
Published: April 8, 2025, 1:11 p.m.
Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer - Oncology Nurse Advisor
Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer Oncology Nurse Advisor
Published: April 8, 2025, 4 a.m.
Sexual dysfunction and quality of life in cervical and endometrial cancer patients before and after low-dose-rate brachytherapy: a cohort study - Frontiers
Sexual dysfunction and quality of life in cervical and endometrial cancer patients before and after low-dose-rate brachytherapy: a cohort study Frontiers
Published: April 4, 2025, 8:35 p.m.
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com
Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com
Published: April 4, 2025, 4:30 a.m.
Link copied to clipboard!